Related Experiment Video

Updated: May 25, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K

Current Development of Therapeutic Vaccines in Lung Cancer

Jesus Salvador Flores Banda1, Sanjana Gangane1, Fatima Raza1

  • 1Department of Medicine, University of Texas at Tyler School of Medicine, 11937 US Hwy 271, Tyler, TX 75799, USA.

Vaccines
|February 26, 2025
PubMed

Insights

Cancer vaccines offer a promising immunotherapy approach for lung cancer. Early enrollment and targeting novel tumor neo-antigens are key to overcoming challenges in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

Area of Science:

  • Oncology
  • Immunotherapy
  • Vaccine Development

Background:

  • Cancer vaccines leverage the immune system to target tumor cells, presenting a novel immunotherapy strategy.
  • Lung cancer vaccines have shown potential in early trials, but face challenges like tumor resistance and heterogeneity.

Purpose of the Study:

  • To review current and ongoing clinical trials of lung cancer vaccines.
  • To analyze different vaccine development strategies and their associated challenges.
  • To discuss the potential of cancer vaccines in treating non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

Main Methods:

  • Review of completed and ongoing clinical trials for lung cancer vaccines.
  • Analysis of vaccine strategies, including neo-antigen identification.
  • Discussion of challenges such as tumor heterogeneity and immune evasion.

Main Results:

  • Early-phase trials suggest improved survival with lung cancer vaccination.
  • Advancements in understanding the immune system and vaccine technology enhance therapeutic potential.
  • Challenges persist in advanced-stage cancers and with tumor resistance mechanisms.

Conclusions:

  • Vaccine development for lung cancer, including NSCLC and SCLC, shows promise but requires further research.
  • Targeting early-stage disease and novel tumor neo-antigens are crucial for future success.
  • Overcoming immune evasion and tumor heterogeneity remains a significant hurdle for effective cancer vaccination.
Keywords:
clinical trialslung cancernon-small cell lung cancersmall cell lung cancertherapeutic cancer vaccines

More Related Videos

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

16.8K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.3K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
325
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
462
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K